Clinical trial
The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary…
NCT00001629 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001629 |
|---|---|
| Title | The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function |
| Official title | The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Heart Failure, Congestive, Hypertension, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Angiotensin II type 1 receptor antagonists |
| Enrollment | 49 |
| Start date | Jul 1, 1997 |
| Completion | Sep 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: